about
Definitive, Preoperative, and Palliative Radiation Therapy of Esophageal CancerRadiotherapy and "new" drugs-new side effects?Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases.Basics of Radiation Biology When Treating Hyperproliferative Benign Diseases.Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data.Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges.Nuclear NF-κB expression correlates with outcome among patients with head and neck squamous cell carcinoma treated with primary chemoradiation therapy.Radiochemotherapy for T1G3 bladder cancer.Preoperative versus postoperative chemoradiotherapy for rectal cancer.The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer.Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients.Neoadjuvant radiochemotherapy in rectal cancer: for which patients and tumor stages?Current status of radiation therapy and combined-modality treatment for bladder cancer.Radiotherapy and concurrent radiochemotherapy for rectal cancer.Organ preservation by combined modality treatment in bladder cancer: the European perspective.The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.Neoadjuvant radiotherapy and radiochemotherapy for rectal cancer.High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.Immunomodulatory properties and molecular effects in inflammatory diseases of low-dose x-irradiation.Trimodality treatment and selective organ preservation for bladder cancer.Radiotherapy for bladder cancer.Integration of novel agents into combined-modality treatment for rectal cancer patients.Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer.The role of survivin for radiation therapy. Prognostic and predictive factor and therapeutic target.Adjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patientsEvidence and research in rectal cancer.Treatment options for high-risk T1 bladder cancer: status quo and future perspectives of radiochemotherapy.Molecular targeted treatment and radiation therapy for rectal cancer.A 4-miRNA signature predicts the therapeutic outcome of glioblastoma.A non-linear detection of phospho-histone H2AX in EA.hy926 endothelial cells following low-dose X-irradiation is modulated by reactive oxygen species.Combined-modality treatment for anal cancer: current strategies and future directions.Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?Rectal cancer: state of the art in 2012.Short-course radiation versus long-course chemoradiation for rectal cancer.Biology of brain metastases and novel targeted therapies: time to translate the research.Neoadjuvant short- or long-term radio(chemo)therapy for rectal cancer: how and who should be treated?To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma.EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
P50
Q26753864-CA5BBD79-EAC1-470D-AF2C-4B58CFA9DC0CQ26861498-7865360A-63ED-437F-B67C-10398FE6DD11Q33579145-F74DF1C7-AA73-4658-AF66-BF91050A86C8Q33627808-49BE8C3B-4F60-442A-90BF-CCD61407D2DFQ33652239-29E656EC-20D9-40C5-B665-235209AA1E6EQ33655046-204E3F9B-01FD-4F3B-BB55-485FE0693FBCQ34344102-D7B528CB-B5EE-48E1-8F09-8CA01A35ECEEQ34528694-520E7AEB-68FF-4E81-AE45-56E86FC789C8Q34552041-9A4B11EE-D1F8-40A4-9FBA-E273828C99C7Q34602828-FC59BAA2-C858-4B62-AE69-601018E68BBBQ34637749-34CCCCA8-17BB-4EBE-AB97-46BC8430BC69Q34638544-BD741F50-E284-412D-9E52-4A69E0E7D030Q35146143-8F45F28A-BAD7-48F6-B636-1BABB20A7B3EQ35905425-7B569B45-BC83-4E65-9CF2-48890D3945EEQ35953199-8ABDCC56-EB72-4442-8D09-1E9545AB0BECQ35967836-39314EED-951F-4671-9DBB-B75416A4EEB1Q36015976-CCE33238-138E-42ED-B52A-1ADA02AB1E41Q36069954-4D2D4D11-712E-4CA2-BE8D-110293E3D208Q36112276-6516835B-3528-4E6D-8C8B-10C172E12A0FQ36198307-910DC0FE-ED6F-4BC7-A082-ACAB7CD00CB8Q36275837-0B5EAAC5-2656-484A-8D72-07E42C2165CDQ36678645-929AAC83-D647-4DC5-A396-1934E596D7C7Q36729153-6C8F5843-6ECC-4FAB-9E28-4AE1E62417BDQ36819451-9484838D-02C5-4B08-BB40-6877C6980F99Q36921895-234FEEA3-CB99-4772-B84F-9BA638D94C8EQ36981225-2A8B081E-5C0C-4FFC-9A3B-4FC89B6ACEE7Q37119089-A5A3E154-F8E5-4238-9049-1787DCCEAC71Q37183742-7050C8A1-1833-46DE-A650-3B5FCBFE4727Q37328113-C4ED0022-EC8E-4803-B20D-CBA76E7ED0A2Q37511793-7EC840A8-657E-483F-A062-0AEE99794A3AQ37564551-02DE5550-A0EB-46A3-A96E-0D303B2EF27AQ37720455-EAFB7344-83A1-407C-914B-5C3DA7EC565CQ37768039-A9ABB698-3583-4F76-AAAD-1BDB2C678102Q37817000-D4350076-27BD-428F-AECC-9CD92A8D2CE4Q37997242-2CA79E99-F5B5-4A57-8288-B05712B9318CQ38051235-C733B5AE-1832-4CE4-93DB-0C7B1484EAC3Q38059028-D9F9B9A5-F573-43FD-AE8A-25EFD9C0D7F6Q38064748-6FFB4A58-1F0A-4E45-83D7-DAF8D24430CAQ38105006-06FE089C-9C27-4DCE-808F-DE8CE01B65B7Q38114698-1089E93D-049F-4D26-BCFF-F0872E86D489
P50
name
Claus Rödel
@ast
Claus Rödel
@en
Claus Rödel
@nl
type
label
Claus Rödel
@ast
Claus Rödel
@en
Claus Rödel
@nl
prefLabel
Claus Rödel
@ast
Claus Rödel
@en
Claus Rödel
@nl